Historique de carrière de Magnus Ronn
Anciens postes connus de Magnus Ronn
Sociétés | Poste | Début | Fin |
---|---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/01/2006 | 01/01/2006 |
Roche Colorado Corp.
Roche Colorado Corp. Medical SpecialtiesHealth Technology Roche Colorado Corp. manufactures peptides for commercial pharmaceutical use. It also manufactures drugs such as the anti-HIV treatments Fuzeon, Invirase, and the influenza drug Tamiflu. It also provides contract manufacturing of peptides and a protein-like compound used in pharmaceuticals. The company was founded in 1967 and is headquartered in Boulder, CO. | Directeur Technique/Scientifique/R&D | - | - |
TETRAPHASE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2011 | - |
Formation de Magnus Ronn
The University of Colorado | Undergraduate Degree |
University of Uppsala | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Suède | 2 |
Opérationnelle
Undergraduate Degree | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Roche Colorado Corp.
Roche Colorado Corp. Medical SpecialtiesHealth Technology Roche Colorado Corp. manufactures peptides for commercial pharmaceutical use. It also manufactures drugs such as the anti-HIV treatments Fuzeon, Invirase, and the influenza drug Tamiflu. It also provides contract manufacturing of peptides and a protein-like compound used in pharmaceuticals. The company was founded in 1967 and is headquartered in Boulder, CO. | Health Technology |
- Bourse
- Insiders
- Magnus Ronn
- Expérience